Tsubota Laboratory Incorporated

4890・Growth Market・Pharmaceuticals

Official website

Tsubota Laboratory Incorporated

4890・Growth Market・Pharmaceuticals

Official website

Tsubota Laboratory Incorporated4890

Reference Indicators

Market Cap

61¥100M

P/E (Forecast)

135.6x

P/B

7.0x

Dividend Yield (Forecast)

0.00%

ROE

-88.2%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	640	954	673	1,357	200
Cost of Sales	83	235	652	180	68
Gross Profit	557	719	21	1,176	131
SG&A Expenses	420	552	670	941	919
Operating Income	136	167	-649	235	-787
Non-operating Income	67	4	14	47	27
Non-operating Expenses	1	27	1	1	0
Ordinary Income	202	144	-636	281	-760
Extraordinary Income	—	—	—	—	0
Extraordinary Losses	—	—	—	0	—
Pre-tax Income	202	144	-636	281	-760
Income Taxes	49	54	4	75	0
Net Income	153	90	-641	205	-761
EBITDA	173	206	-613	264	-766
Gross Margin	86.9%	75.3%	3.2%	86.7%	65.8%
Operating Margin	21.2%	17.5%	-96.4%	17.4%	-393.9%
ROA	9.5%	3.4%	-27.9%	8.2%	-57.8%
ROE	23.0%	6.7%	-46.9%	13.9%	-88.2%